Risk of recurrence after local resection of T1 rectal cancer: a meta-analysis with meta-regression
- PMID: 35773606
- PMCID: PMC9652303
- DOI: 10.1007/s00464-022-09396-3
Risk of recurrence after local resection of T1 rectal cancer: a meta-analysis with meta-regression
Abstract
Background: T1 rectal cancer (RC) patients are increasingly being treated by local resection alone but uniform surveillance strategies thereafter are lacking. To determine whether different local resection techniques influence the risk of recurrence and cancer-related mortality, a meta-analysis was performed.
Methods: A systematic search was conducted for T1RC patients treated with local surgical resection. The primary outcome was the risk of RC recurrence and RC-related mortality. Pooled estimates were calculated using mixed-effect logistic regression. We also systematically searched and evaluated endoscopically treated T1RC patients in a similar manner.
Results: In 2585 unique T1RC patients (86 studies) undergoing local surgical resection, the overall pooled cumulative incidence of recurrence was 9.1% (302 events, 95% CI 7.3-11.4%; I2 = 68.3%). In meta-regression, the recurrence risk was associated with histological risk status (p < 0.005; low-risk 6.6%, 95% CI 4.4-9.7% vs. high-risk 28.2%, 95% CI 19-39.7%) and local surgical resection technique (p < 0.005; TEM/TAMIS 7.7%, 95% CI 5.3-11.0% vs. other local surgical excisions 10.8%, 95% CI 6.7-16.8%). In 641 unique T1RC patients treated with flexible endoscopic excision (16 studies), the risk of recurrence (7.7%, 95% CI 5.2-11.2%), cancer-related mortality (2.3%, 95% CI 1.1-4.9), and cancer-related mortality among patients with recurrence (30.0%, 95% CI 14.7-49.4%) were comparable to outcomes after TEM/TAMIS (risk of recurrence 7.7%, 95% CI 5.3-11.0%, cancer-related mortality 2.8%, 95% CI 1.2-6.2% and among patients with recurrence 35.6%, 95% CI 21.9-51.2%).
Conclusions: Patients with T1 rectal cancer may have a significantly lower recurrence risk after TEM/TAMIS compared to other local surgical resection techniques. After TEM/TAMIS and endoscopic resection the recurrence risk, cancer-related mortality and cancer-related mortality among patients with recurrence were comparable. Recurrence was mainly dependent on histological risk status.
Keywords: Follow-up; Local surgical resection; Recurrence; T1 rectal cancer; Therapeutic endoscopy.
© 2022. The Author(s).
Figures







Similar articles
-
Risk and Time Pattern of Recurrences After Local Endoscopic Resection of T1 Colorectal Cancer: A Meta-analysis.Clin Gastroenterol Hepatol. 2022 Feb;20(2):e298-e314. doi: 10.1016/j.cgh.2020.11.032. Epub 2020 Dec 1. Clin Gastroenterol Hepatol. 2022. PMID: 33271339
-
Comparison of Transanal Endoscopic Microsurgery and Total Mesorectal Excision in the Treatment of T1 Rectal Cancer: A Meta-Analysis.PLoS One. 2015 Oct 27;10(10):e0141427. doi: 10.1371/journal.pone.0141427. eCollection 2015. PLoS One. 2015. PMID: 26505895 Free PMC article.
-
Oncological outcome after local treatment for early stage rectal cancer.Surg Endosc. 2022 Jan;36(1):489-497. doi: 10.1007/s00464-021-08308-1. Epub 2021 Feb 5. Surg Endosc. 2022. PMID: 33544250 Free PMC article.
-
Endoscopic submucosal dissection (ESD) versus transanal endoscopic microsurgery (TEM) for treatment of rectal tumors: a comparative systematic review and meta-analysis.Surg Endosc. 2020 Apr;34(4):1688-1695. doi: 10.1007/s00464-019-06945-1. Epub 2019 Jul 10. Surg Endosc. 2020. PMID: 31292744
-
Statistical, Clinical, Methodological Evaluation of Local Recurrence Following Transanal Total Mesorectal Excision for Rectal Cancer: A Systematic Review.Dis Colon Rectum. 2021 Jul 1;64(7):899-914. doi: 10.1097/DCR.0000000000002110. Dis Colon Rectum. 2021. PMID: 33938532
Cited by
-
Treatment Options for Distal Rectal Cancer in the Era of Organ Preservation.Curr Treat Options Oncol. 2024 Apr;25(4):434-452. doi: 10.1007/s11864-024-01194-4. Epub 2024 Mar 22. Curr Treat Options Oncol. 2024. PMID: 38517596 Free PMC article. Review.
-
Outcome of Completion Surgery after Endoscopic Submucosal Dissection in Early-Stage Colorectal Cancer Patients.Cancers (Basel). 2023 Sep 9;15(18):4490. doi: 10.3390/cancers15184490. Cancers (Basel). 2023. PMID: 37760458 Free PMC article.
-
Minimally invasive transanal excision over conventional transanal excision: pursuing the perfect removal of early rectal cancer.Ann Coloproctol. 2025 Apr;41(2):105-106. doi: 10.3393/ac.2025.00479.0068. Epub 2025 Apr 30. Ann Coloproctol. 2025. PMID: 40313125 Free PMC article. No abstract available.
-
Short-term outcomes after primary total mesorectal excision (TME) versus local excision followed by completion TME for early rectal cancer: population-based propensity-matched study.BJS Open. 2024 Sep 3;8(5):zrae103. doi: 10.1093/bjsopen/zrae103. BJS Open. 2024. PMID: 39235090 Free PMC article.
-
Local excision for middle-low rectal cancer after neoadjuvant chemoradiation: A retrospective study from a single tertiary center.World J Gastrointest Oncol. 2024 Dec 15;16(12):4614-4624. doi: 10.4251/wjgo.v16.i12.4614. World J Gastrointest Oncol. 2024. PMID: 39678786 Free PMC article.
References
-
- Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019;394(10207):1467–1480. - PubMed
-
- Lezoche E, Paganini AM, Fabiani B, et al. Quality-of-life impairment after endoluminal locoregional resection and laparoscopic total mesorectal excision. Surg Endosc. 2014;28(1):227–234. - PubMed
-
- Bennis M, Parc Y, Lefevre JH, et al. Morbidity risk factors after low anterior resection with total mesorectal excision and coloanal anastomosis: a retrospective series of 483 patients. Ann Surg. 2012;255(3):504–510. - PubMed
-
- van Groningen JT, van Hagen P, Tollenaar R, et al. Evaluation of a Completion Total Mesorectal Excision in Patients After Local Excision of Rectal Cancer: A Word of Caution. J Natl Compr Canc Netw. 2018;16(7):822–828. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources